Cargando…
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection
BACKGROUND: The duration and effectiveness of immunity from infection with and vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are relevant to pandemic policy interventions, including the timing of vaccine boosters. METHODS: We investigated the duration and effective...
Autores principales: | Hall, Victoria, Foulkes, Sarah, Insalata, Ferdinando, Kirwan, Peter, Saei, Ayoub, Atti, Ana, Wellington, Edgar, Khawam, Jameel, Munro, Katie, Cole, Michelle, Tranquillini, Caio, Taylor-Kerr, Andrew, Hettiarachchi, Nipunadi, Calbraith, Davina, Sajedi, Noshin, Milligan, Iain, Themistocleous, Yrene, Corrigan, Diane, Cromey, Lisa, Price, Lesley, Stewart, Sally, de Lacy, Elen, Norman, Chris, Linley, Ezra, Otter, Ashley D., Semper, Amanda, Hewson, Jacqueline, D’Arcangelo, Silvia, Chand, Meera, Brown, Colin S., Brooks, Tim, Islam, Jasmin, Charlett, Andre, Hopkins, Susan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Massachusetts Medical Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908850/ https://www.ncbi.nlm.nih.gov/pubmed/35172051 http://dx.doi.org/10.1056/NEJMoa2118691 |
Ejemplares similares
-
Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN study
por: Atti, Ana, et al.
Publicado: (2022) -
Early Warning Surveillance for SARS-CoV-2 Omicron Variants, United Kingdom, November 2021–September 2022
por: Foulkes, Sarah, et al.
Publicado: (2023) -
COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study
por: Hall, Victoria Jane, et al.
Publicado: (2021) -
Implementation and Extended Evaluation of the Euroimmun Anti-SARS-CoV-2 IgG Assay and Its Contribution to the United Kingdom’s COVID-19 Public Health Response
por: Otter, Ashley David, et al.
Publicado: (2022) -
Focus on the potential role of ficlatuzumab in the treatment of non-small cell lung cancer
por: D’Arcangelo, Manolo, et al.
Publicado: (2013)